I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 14 studies | 21% ± 6% | |
| endothelial cell | 13 studies | 24% ± 7% | |
| epithelial cell | 8 studies | 31% ± 13% | |
| ciliated cell | 8 studies | 27% ± 11% | |
| epithelial cell of proximal tubule | 6 studies | 41% ± 11% | |
| plasmacytoid dendritic cell | 6 studies | 23% ± 7% | |
| memory B cell | 6 studies | 18% ± 2% | |
| kidney loop of Henle epithelial cell | 5 studies | 28% ± 6% | |
| natural killer cell | 5 studies | 21% ± 4% | |
| fibroblast | 5 studies | 22% ± 5% | |
| cardiac muscle cell | 5 studies | 22% ± 3% | |
| hepatocyte | 5 studies | 40% ± 17% | |
| GABAergic neuron | 5 studies | 37% ± 16% | |
| astrocyte | 5 studies | 31% ± 9% | |
| glutamatergic neuron | 5 studies | 48% ± 23% | |
| oligodendrocyte precursor cell | 5 studies | 27% ± 9% | |
| oligodendrocyte | 5 studies | 24% ± 5% | |
| hematopoietic precursor cell | 4 studies | 23% ± 6% | |
| plasma cell | 4 studies | 26% ± 13% | |
| plasmablast | 4 studies | 41% ± 16% | |
| renal alpha-intercalated cell | 4 studies | 41% ± 6% | |
| myeloid cell | 4 studies | 19% ± 5% | |
| precursor B cell | 4 studies | 26% ± 7% | |
| retinal cone cell | 4 studies | 28% ± 9% | |
| macrophage | 4 studies | 21% ± 3% | |
| adipocyte | 4 studies | 24% ± 4% | |
| interneuron | 4 studies | 36% ± 20% | |
| microglial cell | 3 studies | 21% ± 3% | |
| smooth muscle cell | 3 studies | 16% ± 1% | |
| enterocyte | 3 studies | 18% ± 2% | |
| pro-B cell | 3 studies | 30% ± 6% | |
| rod bipolar cell | 3 studies | 22% ± 1% | |
| germinal center B cell | 3 studies | 25% ± 2% | |
| endothelial cell of lymphatic vessel | 3 studies | 20% ± 5% | |
| abnormal cell | 3 studies | 32% ± 3% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 32% ± 19% | |
| enteroendocrine cell | 3 studies | 24% ± 8% | |
| intestinal crypt stem cell | 3 studies | 21% ± 1% | |
| basal cell | 3 studies | 33% ± 7% | |
| transit amplifying cell | 3 studies | 23% ± 7% | |
| neuron | 3 studies | 36% ± 8% | |
| hematopoietic stem cell | 3 studies | 16% ± 1% |
